EPISODE 143
In this episode, Mike Favet, the new CEO of NeuroPace, shares his personal story into Medtech and reveals his plans for one of Medtech’s pioneers, NeuroPace. What convinced him to become CEO? What changes will he make at NeuroPace?
Podcast Guest
Mike Favet
CEO
NeuroPace
Michael Favet has 20 years of senior management experience with medical technology companies. He has served on the NeuroPace Board of Directors since 2016 and served as the company’s Chief Commercial Officer prior to assuming the role of Chief Executive Officer in 2019.
Prior to joining NeuroPace, Mr. Favet held various executive-level positions for companies including Advanced Cardiac Therapeutics, Sonitus Medical, Ventus Medical, Boston Scientific and Guidant. Most recently, Mr. Favet was a managing director for KCK’s medtech group, part of a fund for medical technology investments.
Mr. Favet received a BS in Mechanical Engineering from the University of Illinois and an MBA from the University of Minnesota.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.